Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?

Imagem de Miniatura
Arquivos
art_SAUD_Hepatocellular_carcinoma_in_patients_coinfected_with_hepatitis_B_2021.PDF (545.2 KB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
HORVAT, Natally
Citação
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, v.33, n.4, p.583-588, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction and objectives Hepatocellular carcinoma (HCC) is the 6th cause of cancer and hepatitis C (HCV) and B (HBV) viruses are the most frequent risk factors for HCC. Patients coinfected with HCV or HBV and HIV present a faster progression to liver fibrosis and higher incidence of HCC. The aim of this study was to evaluate the survival and clinical outcomes of coinfected patients with HCC comparing with non-HIV patients. Methods We conducted a retrospective cohort study, including 267 HCC patients with HCV or HBV infection with or without HIV. The primary endpoint was overall survival. A Kaplan-Meier curve was presented to assess survival function. Clinical and radiologic variables, according to HIV status, were compared by logistic regression. Results Among 267 HCC patients, 25 (9.3%) were HIV-positive. In the coinfected group, patients were younger (49.8 vs 61.2 years, P < 0.001), cirrhosis was less predominant (88 vs 96.7%, P = 0.05), a smaller proportion received HCC treatment (60 vs 86.3%, P = 0.001) and the frequency of portal vein tumoral thrombosis was higher (32 vs 11.1%, P = 0.003). The overall mortality rate was higher in the HIV-positive group (92 vs 74.3%), independently of clinical and tumoral variables. Conclusion Coinfected patients with HCC presented higher mortality, tumor diagnosis in a younger age, less underlying cirrhosis and a higher frequency of tumoral thrombosis. Further studies are warranted to better understand the role of HIV in hepatocarcinogenesis, in order to improve the management of those patients, particularly regarding screening programs.
Palavras-chave
cirrhosis, hepatitis B virus, hepatitis C virus, HIV, hepatocellular carcinoma, highly active antiretroviral
URI
https://observatorio.fm.usp.br/handle/OPI/40706
Referências
  1. [Anonymous], 2019, GLOB HIV AIDS STAT 2, V1, P1
  2. Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409
  3. Berretta M, 2011, ONCOLOGIST, V16, P1258, DOI 10.1634/theoncologist.2010-0400
  4. Bonnard P, 2007, J VIRAL HEPATITIS, V14, P806, DOI 10.1111/j.1365-2893.2007.00874.x
  5. Brau N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010
  6. Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
  7. Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933
  8. Deng LP, 2009, WORLD J GASTROENTERO, V15, P996, DOI 10.3748/wjg.15.996
  9. European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
  10. Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2
  11. Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283
  12. Gramenzi A, 2013, DIGEST LIVER DIS, V45, P516, DOI 10.1016/j.dld.2012.12.010
  13. Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800
  14. Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6
  15. Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe
  16. Marcon PD, 2018, WORLD J GASTROENTERO, V24, P613, DOI 10.3748/wjg.v24.i5.613
  17. Massard J, 2006, J HEPATOL, V44, pS19, DOI 10.1016/j.jhep.2005.11.009
  18. Merchante N, 2013, CLIN INFECT DIS, V56, P143, DOI 10.1093/cid/cis777
  19. Pinato DJ, 2017, AIDS, V31, P603, DOI 10.1097/QAD.0000000000001422
  20. Puoti M, 2004, AIDS, V18, P2285, DOI 10.1097/00002030-200411190-00009
  21. Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015
  22. Sarmati L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111077
  23. Sherman KE, 2017, HEPATOL COMMUN, V1, P987, DOI 10.1002/hep4.1112
  24. Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009
  25. Torgersen J, 2019, J CHEM INF MODEL, V53, P1689
  26. Weber R, 2006, ARCH INTERN MED, V166, P1632

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/07
Carregar mais